Large portfolio of novel bacteria to fight cancer

Redbiotec is currently engineering and producing a number of novel E. coli bacteria strains. These strains are expected to show superior features in Redbiotec’s COMOs and in further applications. Based on the current and upcoming results Redbiotec plans to file an additional patent application by Q4 2018.


2018-06-19T15:52:52+00:00March 26th, 2018|Home, News|